These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32308618)

  • 1. Mitochondrial Dysfunction and Parkinson's Disease-Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy.
    Foo ASC; Soong TW; Yeo TT; Lim KL
    Front Aging Neurosci; 2020; 12():89. PubMed ID: 32308618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy.
    Gao XY; Yang T; Gu Y; Sun XH
    Front Aging Neurosci; 2022; 14():885500. PubMed ID: 35795234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photobiomodulation for Parkinson's Disease in Animal Models: A Systematic Review.
    Salehpour F; Hamblin MR
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potentials of Near-Infrared II Photobiomodulation to Treat Cerebrovascular Diseases via Nitric Oxide Signalling.
    Kashiwagi S; Yokomizo S; Bragin DE; Perle SJ; Kastanenka KV; Gerashchenko D; Atochin DN
    Adv Exp Med Biol; 2024; 1463():195-200. PubMed ID: 39400823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's Disease and Photobiomodulation: Potential for Treatment.
    Bicknell B; Liebert A; Herkes G
    J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38276234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-conditioning with Remote Photobiomodulation Modulates the Brain Transcriptome and Protects Against MPTP Insult in Mice.
    Ganeshan V; Skladnev NV; Kim JY; Mitrofanis J; Stone J; Johnstone DM
    Neuroscience; 2019 Feb; 400():85-97. PubMed ID: 30625333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in Parkinson's disease.
    Hu Q; Wang G
    Transl Neurodegener; 2016; 5():14. PubMed ID: 27453777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction.
    Cassano P; Dording C; Thomas G; Foster S; Yeung A; Uchida M; Hamblin MR; Bui E; Fava M; Mischoulon D; Iosifescu DV
    Lasers Surg Med; 2019 Feb; 51(2):127-135. PubMed ID: 30221776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.
    Li H; Sun B; Huang Y; Zhang J; Xu X; Shen Y; Chen Z; Yang J; Shen L; Hu Y; Gu H
    Mol Med; 2022 Mar; 28(1):29. PubMed ID: 35255803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of Na
    Xing R; Liu X; Tian B; Cheng Y; Li L
    Drug Dev Res; 2021 Nov; 82(7):969-979. PubMed ID: 33538000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial application of near-infrared light in a hemi-parkinsonian rat model: the impact on behavior and cell survival.
    Reinhart F; Massri NE; Chabrol C; Cretallaz C; Johnstone DM; Torres N; Darlot F; Costecalde T; Stone J; Mitrofanis J; Benabid AL; Moro C
    J Neurosurg; 2016 Jun; 124(6):1829-41. PubMed ID: 26613166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Photobiomodulation Therapy: a Narrative Review.
    Salehpour F; Mahmoudi J; Kamari F; Sadigh-Eteghad S; Rasta SH; Hamblin MR
    Mol Neurobiol; 2018 Aug; 55(8):6601-6636. PubMed ID: 29327206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease.
    Jiang X; Jin T; Zhang H; Miao J; Zhao X; Su Y; Zhang Y
    Oxid Med Cell Longev; 2019; 2019():4578462. PubMed ID: 31485291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms.
    Caldieraro MA; Cassano P
    J Affect Disord; 2019 Jan; 243():262-273. PubMed ID: 30248638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging neuroprotective effect of metformin in Parkinson's disease: A molecular crosstalk.
    Paudel YN; Angelopoulou E; Piperi C; Shaikh MF; Othman I
    Pharmacol Res; 2020 Feb; 152():104593. PubMed ID: 31843673
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Mallach A; Weinert M; Arthur J; Gveric D; Tierney TS; Alavian KN
    FASEB J; 2019 Jun; 33(6):6957-6961. PubMed ID: 30862197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease.
    Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW
    Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.
    Sohrabi T; Mirzaei-Behbahani B; Zadali R; Pirhaghi M; Morozova-Roche LA; Meratan AA
    J Mol Biol; 2023 Jun; 435(12):167992. PubMed ID: 36736886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.